Covalon Technologies (CVE:COV) Stock Price Up 1.5%

Shares of Covalon Technologies Ltd. (CVE:COVGet Rating) rose 1.5% on Tuesday . The stock traded as high as C$1.99 and last traded at C$1.99. Approximately 900 shares were traded during trading, a decline of 83% from the average daily volume of 5,433 shares. The stock had previously closed at C$1.96.

The firm’s 50-day moving average price is C$2.11 and its 200 day moving average price is C$2.27. The firm has a market cap of C$51.54 million and a P/E ratio of 2.30. The company has a quick ratio of 6.36, a current ratio of 8.51 and a debt-to-equity ratio of 7.79.

Covalon Technologies (CVE:COVGet Rating) last issued its quarterly earnings results on Tuesday, March 1st. The company reported C($0.04) earnings per share for the quarter. The business had revenue of C$4.94 million for the quarter. On average, equities analysts predict that Covalon Technologies Ltd. will post 0.3 earnings per share for the current year.

About Covalon Technologies (CVE:COV)

Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has 3 proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity; and medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device.

Read More

Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with's FREE daily email newsletter.